Micah L. Berman, B.A., J.D.
Education and Experience
-
BA, Brandeis University
-
JD, Stanford Law School
Biography
Micah Berman is a nationally prominent expert in public health law. He serves as both a professor of law and the Stephen F. Loebs Professor in Health Services Management and Policy in the College of Public Health.
Professor Berman’s scholarship examines the intersection between public health research and legal doctrine, and he is a co-author of The New Public Health Law: A Transdisciplinary Approach to Practice and Advocacy (Oxford University Press, 2nd ed. 2022). He has published articles in leading law, public health, and medical journals, including the Georgetown Law Journal, the Boston College Law Review, the American Journal of Public Health, and the New England Journal of Medicine.
Prior to joining Ohio State, Berman was a member of the faculty at New England Law | Boston, where he established and directed the Center for Public Health and Tobacco Policy. He also previously taught at Capital University Law School and directed the Ohio Tobacco Public Policy Center.
Professor Berman has been engaged in public health policy development at the local, state, federal, and international levels. He has served as an advisor to the Food and Drug Administration’s Center for Tobacco Products and as a visiting scholar at the World Health Organization’s Center for International Cooperation on Tobacco Control. In recognition of his outstanding contributions to public health and tobacco control through both research and advocacy, Professor Berman has received the David P. Rall Award for Advocacy in Public Health from the American Public Health Association (2021) and the John Slade Award from the Society for Research on Nicotine & Tobacco (2023).
The Bridge Builder: Charity Scott’s Expansive Vision for Lawyers, Health, and Society, 52 J.L. Med. & Ethics 328 (2024)
Legal Work of Public Health Professionals: The Case for Better Professional Education, 139 Pub. Health Reports 519 (2024)
Spree Bar, a Vaping System Delivering a Synthetic Nicotine Analogue, Marketed in the United States as “PMTA Exempt”, Tobacco Control (March 2024) (online first).
Editorial, Commercial Tobacco and Nicotine Industry-funded Research Has No Place in SRNT and Nicotine & Tobacco Research, 26 Nicotine & Tobacco Res. 963 (2024)
How to Advance Legal Education for Future Public Health Professionals, Pub. Health Reports (Sept. 2024) (online first).
'Cashing In’ Nicotine Pouches for Prizes, Tobacco Control (June 2024) (online first).
Oral Nicotine Pouch Manufacturer’s Reduced Exposure Claims Require Evidence and Regulatory Oversight, Tobacco Control (May 2024) (online first).
E-Cigarettes, the FDA, Public Health, and Harm Reduction: A Response to the Open Peer Commentaries, 23 Am. J. Bioethics W1 (2023)
External Review of FDA Regulation of Opioid Analgesics (2023).
Synthetic Nicotine: Science, Global Legal Landscape and Regulatory Considerations (2023).